Jaydess (Levonorgestrel)

Levonorgestrel released from the device acts locally on the endometrium to suppress its growth, thickens cervical mucus to block sperm entry, and interferes with the hormonal signals that trigger ovulation, thereby preventing fertilisation and implantation.

Jaydess contains a fixed 13.5 mg amount of levonorgestrel within the intrauterine system. The prescribing clinician determines the appropriate use and duration; no patient‑adjusted dosing is required.

Jaydess is classified as Pregnancy Category X, meaning it must not be used by women who are pregnant. It is not recommended for breastfeeding mothers until the device is removed, as levonorgestrel may be excreted in breast milk.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Jaydess contains a lower levonorgestrel dose (13.5 mg) compared with devices such as Mirena (52 mg), offering a similar contraceptive effect with a potentially reduced hormonal side‑effect profile. Both provide long‑acting reversible contraception, but Jaydess is approved for up to three years of use.

Jaydess should be stored at ambient temperature, below 25 °C, in its original sealed packaging. Protect the device from moisture, direct sunlight and extreme temperature fluctuations to maintain its integrity until insertion.

Jaydess is inserted by a trained healthcare professional into the uterine cavity through the cervical canal. The procedure is performed in a clinical setting using a sterile inserter, and the device remains in place to release levonorgestrel continuously for up to three years.

Serious risks include uterine perforation during insertion, device expulsion, pelvic inflammatory disease, and the rare possibility of ectopic pregnancy if contraceptive failure occurs. Prompt medical evaluation is essential if severe abdominal pain, abnormal bleeding, or signs of infection develop.

Women with active pelvic infection, unexplained vaginal bleeding, known hypersensitivity to levonorgestrel, or a history of uterine perforation should avoid Jaydess. It is also contraindicated in pregnant women and those who are currently breastfeeding.